AURYXIA (nda205874)- (EQ 210MG IRON)

Generic Name	FERRIC CITRATE	Innovator	KERYX BIOPHARMS
Dosage	EQ 210MG IRON
ParaIV Filing	Yes	505(b)2 Filing	Yes
Last Patent Expiry	2030-Jul-21	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Ferric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	21

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 210MG IRON	**	**	Up	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of AURYXIA